Multiple myeloma (MM) is a type of cancer that affects the plasma cells in the bone marrow. This cancer accounts for a significant proportion of non-organ specific cancers and is the fourth most common cancer diagnosed among women. MM can affect anyone, but it is rare among children and young adults. In contrast, men are more commonly affected than women. Treatment options include chemotherapy, radiation, immunotherapy, and stem cell transplantation, where possible.
The pathogenesis of MM involves changes in the plasma circulars, which are responsible for producing immunoglobulin proteins. Tumour tissues infiltrate bone, and one type of paraprotein is typically made – IgG or IgM. Paraproteins can cause numerous autoimmune manifestations that include hemolysis, nephrocalcinosity, anemia, neuropathy, physical fatigue, infections, and increased risk of autoantibodies. These symptoms might not manifest until months or even years in advance, so omni-sensitizing testing cannot be specified only for the diagnosis of MM. Tissue involvement can lead to compression of the spin, gradually impacting the subsequent neurological development in people with MM. Additionally, promoting tumor cells can take place alongside of other conditions, such as fungal infections. Kidney preservation difficulties frequently accompany MM, like dialysis use, hypertension, abnormal urine frequency,